IL1B and type 2 diabetes mellitus: Several in vitro, in vivo studies and clinical trials provide evidence that supports a causative role of IL-1β in the pathogenesis of type 2 diabetes [15], and elevation in circulating levels of IL-1β predicts type 2 diabetes when combined with serum IL-6 levels [16].